Guangzhou Baiyunshan Pharma (874:HK) PT Lowered to HK$21.40 at Morgan StanleyMorgan Stanley analyst Laurence Tam lowered the price target on Guangzhou Baiyunshan Pharma (874:HK) to HK$21.40 (from HK$21.70) while maintaining a Equalweight rating.

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Unknown Analyst

Citi

Not Ranked

Citi

HK$14.5

Sell

-21.41%

Downside

Reiterated

08/27/25

Unknown Analyst

Bank of America Securities

Not Ranked

Bank of America Securities

HK$22

Buy

19.24%

Upside

Reiterated

08/18/25

Laurence Tam

Morgan Stanley

HK$21.7→HK$21.4

Hold

15.99%

Upside

Reiterated

12/23/24

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Guangzhou Baiyunshan Pharmaceutical Holdings Company

1 Month

xxx

Success Rate

1/2 ratings generated profit

Average Return

+1.10%

reiterated a xxx

rating 2 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 50.00% of your transactions generating a profit, with an average return of +1.10% per trade.

3 Months

xxx

Success Rate

1/2 ratings generated profit

Average Return

-3.15%

reiterated a xxx

rating 2 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 50.00% of your transactions generating a profit, with an average return of -3.15% per trade.

1 Year

Bryce GeneronTR | OpenAI - 4o

Success Rate

0/2 ratings generated profit

Average Return

-7.45%

reiterated a buy rating 2 months ago

Copying Bryce Generon's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -7.45% per trade.

2 Years

xxx

Success Rate

0/2 ratings generated profit

Average Return

-7.45%

reiterated a xxx

rating 2 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -7.45% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

0874 Analyst Recommendation Trends

Rating

Dec 24

Feb 25

Apr 25

Aug 25

Oct 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, 0874 has received 7 Buy Ratings, 1 Hold Ratings, and 1 Sell Ratings. 0874 average Analyst price target in the past 3 months is ―.

Each month's total comprises the sum of three months' worth of ratings.

0874 Stock Forecast FAQ

What is HK:0874’s average 12-month price target, according to analysts?

Currently, no data Available

What is HK:0874’s upside potential, based on the analysts’ average price target?

Currently there's no upside potential for HK:0874, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H a Buy, Sell or Hold?

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H has a consensus rating of Moderate Sell, which is based on 0 buy ratings, 0 hold ratings and 0 sell ratings.

What is Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H’s share price target?

Currently, no data Available

What do analysts say about Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H?

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H’s analyst rating consensus is a Moderate Sell. This is based on the ratings of 0 Wall Streets Analysts.

How can I buy shares of Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H?

To buy shares of HK:0874, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

Guangzhou Baiyunshan Pharmaceutical Holdings Company (0874) Stock Forecast & Price Target

0874 Financial Forecast

0874 Earnings Forecast

0874 Sales Forecast

Detailed List of Analyst Forecasts​

Best Analysts Covering Guangzhou Baiyunshan Pharmaceutical Holdings Company

0874 Analyst Recommendation Trends

0874 Stock Forecast FAQ

Detailed List of Analyst Forecasts